Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles

References

• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463–468.
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98:E769–E778.
   PubMed Web of Science ®Google Scholar
• Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013;8:e60563.
   PubMed Web of Science ®Google Scholar
• Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28–38.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Gynecology: ACOG practice bulletin no. 108: polycystic ovary syndrome. Obstet Gynecol. 2009;114:936–949.
   PubMedGoogle Scholar
• Wild R, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a position statement by the Androgen Excess & Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95:2038–2049.
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456–488.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 1997;20:1087–1092.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang XY, Sun Y, et al. Higher circulating irisin levels in patients with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2018;34:290–293.
   PubMed Web of Science ®Google Scholar
• Chang CL, Huang SY, Soong YK, et al. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome. J Clin Endocrinol Metab. 2014;99:E2539–E2548.
   PubMed Web of Science ®Google Scholar
• Bostanci MS, Akdemir N, Cinemre B, et al. Serum irisin levels in patients with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2015;19:4462–4468.
   PubMed Web of Science ®Google Scholar
• Acet M, Celik N, Acet T, et al. Serum and follicular fluid irisin levels in poor and high responder women undergoing IVF/ICSI. Eur Rev Med Pharmacol Sci. 2016;20:1940–1946.
   PubMed Web of Science ®Google Scholar
• Li H, Xu X, Wang X, et al. Free androgen index and Irisin in polycystic ovary syndrome. J Endocrinol Invest. 2016;39:549–556.
   PubMed Web of Science ®Google Scholar
• Adamska A, Karczewska-Kupczewska M, Lebkowska A, et al. Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome. Endocr J. 2016;63:1107–1112.
   PubMed Web of Science ®Google Scholar
• Choi YK, Kim MK, Bae KH, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013;100:96–101.
   PubMed Web of Science ®Google Scholar
• Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complicat. 2013;27:365–369.
   PubMed Web of Science ®Google Scholar
• Pukajlo K, Laczmanski L, Kolackov K, et al. Irisin plasma concentration in PCOS and healthy subjects is related to body fat content and android fat distribution. Gynecol Endocrinol. 2015;25:1–5.
   Google Scholar
• Abali R, Yuksel IT, Yuksel MA, et al. Implications of circulating irisin and Fabp4 levels in patients with polycystic ovary syndrome. J Obstet Gynecol. 2016;2016:1–5.
   Google Scholar
• Aydin S. A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides. 2015;72:4–15.
   PubMed Web of Science ®Google Scholar
• Sanchis-Gomar F, Alis R, Pareja-Galeano H, et al. Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine. 2014;46:674–677.
   PubMed Web of Science ®Google Scholar
• Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899–4907.
   PubMed Web of Science ®Google Scholar
• Polak K, Czyzyk A, Simoncini T, et al. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest. 2017;40:1–8.
   PubMed Web of Science ®Google Scholar
• Wild RA, Rizzo M, Clifton S, et al. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95:1073–1079.
   PubMed Web of Science ®Google Scholar
• Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association. Endocr Rev. 2003;24:302–312.
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Bi˙ri˙ A, Bukan N, et al. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Gynecol Endocrinol. 2005;20:258–263.
   PubMed Web of Science ®Google Scholar
• Badawy A, State O, El Gawad SSh, et al. Plasma homocysteine and polycystic ovary syndrome: the missed link. Eur J Obstet Gynecol Reprod Biol. 2007;131:68–72.
   PubMed Web of Science ®Google Scholar
• de la Iglesia R, Lopez-Legarrea P, Crujeiras AB, et al. Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. Clin Endocrinol. 2014;81:306–311.
   PubMed Web of Science ®Google Scholar
• Carmina E, Bucchieri S, Mansueto P, et al. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril. 2009;91:1332–1335.
   PubMed Web of Science ®Google Scholar